Smith & Nephew plc (SNN)

NYSE · Healthcare · Medical Devices
$29.83+0.00%As of 2026-11-22 · USD
Last session low $29.81Last session high $30.25
52-week low $26.1252-week high $37.09
Market cap
$12.47B
Sector
Healthcare
P/E (TTM)
20.3x
Dividend yield
2.66%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)48.6In the neutral range (30 to 70)
MACD (12, 26, 9)0.33Below its signal line (0.56); histogram -0.23
Bollinger %B (20, 2)19%Inside the bands (29.31 to 32.07)
SMA 2030.69Price is 2.8% below
SMA 5028.97Price is 3.0% above
SMA 20030.85Price is 3.3% below
ATR (20)2.15% of priceAverage true range per day
52-week position34%In the middle of the 26.12 to 37.09 range

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.

Latest fiscal yearEnded 2025-12-31: revenue of $6.16B and an operating margin of 13.9%.

More in Medical Devices